Skip to main content
Article thumbnail
Location of Repository

Controversies in the Management of Borderline Resectable Proximal Pancreatic Adenocarcinoma with Vascular Involvement

By Olga N. Tucker and Mohamed Rela

Abstract

Synchronous major vessel resection during pancreaticoduodenectomy (PD) for borderline resectable pancreatic adenocarcinoma remains controversial. In the 1970s, regional pancreatectomy advocated by Fortner was associated with unacceptably high morbidity and mortality rates, with no impact on long-term survival. With the establishment of a multidisciplinary approach, improvements in preoperative staging techniques, surgical expertise, and perioperative care reduced mortality rates and improved 5-year-survival rates are now achieved following resection in high-volume centres. Perioperative morbidity and mortality following PD with portal vein resection are comparable to standard PD, with reported 5-year-survival rates of up to 17%. Segmental resection and reconstruction of the common hepatic artery/proper hepatic artery (CHA/PHA) can be performed to achieve an R0 resection in selected patients with limited involvement of the CHA/PHA at the origin of the gastroduodenal artery (GDA). PD with concomitant major vessel resection for borderline resectable tumours should be performed when a margin-negative resection is anticipated at high-volume centres with expertise in complex pancreatic surgery. Where an incomplete (R1 or R2) resection is likely neoadjuvant treatment with systemic chemotherapy followed by chemoradiation as part of a clinical trial should be offered to all patients

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2654339
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). 2111: ECOG 1200: a randomized phase II trial of gemcitabine plus radiotherapy vs gemcitabine, 5-fluorouracil and cisplatin followed by radiotherapy and 5-fluorouracil in patients with locally advanced, potentially resectable pancreatic adenocarcinoma,”
    2. (2006). A multiinstitutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma,”
    3. (2000). andA.Czerniak,“Theimpactoflaparoscopyandlaparoscopic ultrasonography on the management of pancreatic cancer,”
    4. (1999). B o l d ,C .C h a r n s a n g a v e j ,K .R .C l e a r y ,e ta l . ,“ M a j o r vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis,”
    5. (2002). Benefit of venous resection for ductal adenocarcinoma of the pancreatic head,”
    6. (2006). Borderline resectable pancreatic cancer: a new classification for an old challenge,”
    7. (2006). Borderlineresectablepancreaticcancer:definitions,management, and role of preoperative therapy,”
    8. (1996). C o n l o n ,E .D o u g h e r t y ,D .S .K l i m s t r a ,D .G .C o i t
    9. (1995). Carcinoma of the pancreatic head and periampullary region: tumor staging with laparoscopy and laparoscopic ultrasonography,”
    10. (1996). Carcinoma of the periampullary region: who benefits from portal vein resection?”
    11. (2001). Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by
    12. (2008). Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct,” Pancreas,v o l .3 6 ,n o .2 ,p p .
    13. (2003). Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer,”
    14. (2007). Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fineneedle aspiration specimens of the pancreas,”
    15. (2008). En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival
    16. (2002). Endoscopic ultrasound in pancreatic diseases,” Digestive Diseases,
    17. (1991). Evaluation of palliative surgical procedures in unresectable pancreatic cancer,”
    18. (1999). Experience with staging laparoscopy in pancreatic malignancy,”
    19. (2004). Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection,”
    20. (2002). Extended surgery in bilio-pancreatic cancer: the Japanese experience,” Seminars in Oncology,
    21. (2008). Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial,”
    22. (1995). Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer,”
    23. (2003). Helical computed tomography of the pancreas: potential impact of higher concentrated contrast agents and multidetector technology,”
    24. (1996). Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer,”
    25. (2000). Impact of laparoscopic staging in the treatment of pancreatic cancer,”
    26. (2007). Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer,”
    27. (2006). Indications and techniques of extended resection for pancreatic cancer,”
    28. (2005). Intraportal endovascular ultrasound for portal vein resection in pancreatic carcinoma,”
    29. (1999). Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carcinoma,”
    30. (2000). Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?”
    31. (1998). Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?”
    32. (2001). Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?”
    33. (1996). Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection?”
    34. (2005). Laparoscopic staging,” in Pancreatic Cancer,D .D .v o nH o ff,D .B .E v a n s ,a n dR
    35. (1998). Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer,”
    36. (1999). Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: critical appraisal,”
    37. (2001). Laparoscopy in the staging of pancreatic cancer,”
    38. (1999). Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma,”
    39. (2000). Laparoscopyandperitonealcytologyinthestagingofpancreatic cancer,”
    40. (2002). Locoregional chemotherapy for patients with pancreatic cancer intraarterial adjuvant chemotherapy after pancreatectomy with portal vein resection,”
    41. (1995). m e l m a n ,L .T .d eW i t ,O .M .v a nD e l d e n ,e t al., “Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region,”
    42. (2002). Multidetector row helical CT of the pancreas: value of three-dimensional images, two-dimensional reformations, and contrast-enhanced multiphasic imaging,”
    43. (2005). Pancreatectomy combined with superior mesenteric-portal
    44. (1988). Pancreatic cancer in 1988: possibilities and probabilities,”
    45. (2004). Pancreatic cancer registry in Japan: 20 years of experience,”
    46. (1998). Pancreatic cancer.Laparoscopicstagingandperitonealcytology,”Surgical Oncology Clinics of
    47. (2001). Pancreatic carcinoma: imaging update
    48. (2003). Pancreatic carcinoma: theroleofhigh-resolutionmultislicespiralCTinthediagnosis and assessment of resectability,”
    49. (2006). Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head,”
    50. (2004). Pancreaticoduodenectomy with vascular resection: margin status and survival duration,”
    51. (1996). Pancreaticoduodenectomy: does it have a role in the palliation of pancreatic cancer?”
    52. (2004). Pancreatoduodenectomy with vascular reconstruction in treating carcinoma of the pancreatic head,”
    53. (1999). Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass,”
    54. (1994). Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head,”
    55. (1999). Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma,”
    56. (2006). Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection,”
    57. (2003). Preoperative assessment of pancreatic malignancy using endoscopicultrasound,”AbdominalImaging,v ol.28,no .4,pp .
    58. (2008). Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy,”
    59. (2005). Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques,”
    60. (1993). Prognostic indicators for survival after resection of pancreatic adenocarcinoma,”
    61. (2001). Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma,”
    62. (2006). Rationale and appropriate use of chemotherapy and radiotherapy for pancreatic ductal adenocarcinoma,”
    63. (1996). Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence,”
    64. (1973). Regional resection of cancer of the pancreas: a new surgical approach,”
    65. (2000). Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma,”
    66. (1999). Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis,”
    67. (1999). Role of EUS in the preoperative staging of pancreatic cancer: a large singlecenter experience,”
    68. (2001). Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy,”
    69. (2007). Signifi-cance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma,”
    70. (1997). Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes,”
    71. (1997). Staging laparoscopy with laparoscopic ultrasonography:optimizingresectabilityinhepatobiliaryand pancreatic malignancy,”
    72. (1984). Surgical palliation of unresectable carcinoma of the pancreas,”
    73. (1990). Surgical palliationforpancreaticcancer:theUCLAexperience,”
    74. (2003). Survival benefits of portal vein resection for pancreatic cancer,”
    75. (2002). T.Yoshida,T.Matsumoto,Y.Morii,etal.,“Stagingwithhelical computed tomography and laparoscopy in pancreatic head cancer,” Hepato-Gastroenterology,
    76. (1988). The diagnosis of pancreatic cancer by endoscopic ultrasonography,”
    77. (1999). The use of diagnostic laparoscopy supported by laparoscopic ultrasonography in the assessment of pancreatic cancer,”
    78. (1994). Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms,”
    79. (1997). u m s t a d t ,M .S c h w a b ,K .S c h u s t e r ,E .H a g m ¨
    80. (2005). Value of magnetic resonance angiography combined with magnetic resonance cholangiopancreatography on diagnosis for patients with carcinoma of head of pancreas,”
    81. (2007). Vascular resection and reconstruction for pancreatic malignancy: a single center survival study,”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.